Transmitted antiretroviral drug resistance and thumb subdomain polymorphisms among newly HIV type 1 diagnosed patients infected with CRF01-AE and CRF07-BC virus in Guangdong Province, China

AIDS Research and Human Retroviruses

Volumn 28, Issue 12, 2012, Pages 1723-1728

  Yang, Changfu ^a   Liu, Shuyuan ^b   Zhang, Taisong ^b   Hou, Yaping ^a   Liu, Xiaoli ^b   Gao, Yun ^a   Yang, Guang ^a   Wang, Zhen ^a   Chen, Huayun ^b   Li, Ming ^b   Zhu, Zhenyu ^a,b  

^a SUN YAT SEN UNIVERSITY   (China)

^b SUN YAT SEN UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

NONNUCLEOSIDE REVERSE TRANSCRIPTASE INHIBITOR; PROTEINASE; PROTEINASE INHIBITOR; RNA DIRECTED DNA POLYMERASE INHIBITOR;

ADULT; ARTICLE; CD4 LYMPHOCYTE COUNT; CHINA; CODON; DNA POLYMORPHISM; DRUG RESISTANCE; FEMALE; GENE AMPLIFICATION; GENE MUTATION; GENE SEQUENCE; GENOTYPE; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; MAJOR CLINICAL STUDY; MALE; NUCLEOTIDE SEQUENCE; PHYLOGENY; PREVALENCE; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TRANSMITTED DRUG RESISTANCE; VIRUS GENE; VIRUS LOAD; VIRUS STRAIN;

ADULT; ANTI-RETROVIRAL AGENTS; CHINA; CLUSTER ANALYSIS; DRUG RESISTANCE, VIRAL; FEMALE; GENOTYPE; HIV INFECTIONS; HIV PROTEASE; HIV REVERSE TRANSCRIPTASE; HIV-1; HUMANS; MALE; MIDDLE AGED; MOLECULAR SEQUENCE DATA; PHYLOGENY; POLYMORPHISM, GENETIC; SEQUENCE ANALYSIS, DNA;

EID: 84870013334     PISSN: 08892229     EISSN: 19318405     Source Type: Journal    
DOI: 10.1089/aid.2011.0320     Document Type: Article

References (20)

1. Department of Public Health, Guangdong province: The report of HIV/AIDS prevention and control work in 2011. Available at http://zwgk.gd.gov.cn/ 006940132/201112/t20111206-294678.html? Last accessed 12/04/2011 (in Chinese).
2. Liao L, Xing H, Shang H, et al.: The prevalence of transmitted antiretroviral drug resistance in treatment-naive HIV-infected individuals in China. J Acquir Immune Defic Syndr 2010;53:10-14.
3. Laeyendecker O, Zhang GW, Quinn TC, et al.: Molecular epidemiology of HIV-1 subtypes in southern China. J Acquir Immune Defic Syndr 2005;38:356-362.
4. Deng W, Fu P, Bao LL, et al.: Molecular epidemiological tracing of HIV-1 outbreaks in Hainan island of southern China. AIDS 2009;23:977-985.
5. Li JY, Li HP, Li L, et al.: Prevalence and evolution of drug resistance HIV-1 variants in Henan, China. Cell Res 2005; 15:843-849.
6. Zhao B, Han XX, Dai D, et al.: New trends of primary drug resistance among HIV Type 1-infected men who have sex with men in Liaoning Province, China. AIDS Res Hum Retroviruses 2011;27:1-4.
7. Hattori J, Shiino T, Gatanaga H, et al.: Trends in transmitted drug-resistant HIV-1 and demographic characteristics of newly diagnosed patients: Nationwide surveillance from 2003 to 2008 in Japan. Antiviral Res 2010;88:72-79.
8. Nguyen HT, Duc NB, Shrivastava R, et al.: HIV drug resistance threshold survey using specimens from voluntary counselling and testing sites in Hanoi, Vietnam. Antivir Ther 2008;13:115-121.
9. Kim CO, Chin BS, Han SH, et al.: Low prevalence of drug-resistant HIV-1 in patients newly diagnosed with early stage of HIV infection in Korea. Tohoku J Exp Med 2008;216:259-265.
10. Choi JY, Kim EJ, Park YK, Lee JS, and Kim SS: National survey for drug-resistant variants in newly diagnosed anti-retroviral drug-naive patients with HIV/AIDS in South Korea:1999-2005. J Acquir Immune Defic Syndr 2008; 49:237-242.
11. Bennett DE, Myatt M, Bertagnolio S, et al.: Recommendations for surveillance of transmitted HIV drug resistance in countries scaling up antiretroviral treatment. Antivir Ther 2008;13:25-36.
12. Han X, Zhang M, Dai D, et al.: Genotypic resistance mutations to antiretroviral drugs in treatment-naive HIV/AIDS patients living in Liaoning Province, China: Baseline prevalence and subtype-specific difference. AIDS Res Hum Ret-roviruses 2007;23:357-364.
13. Goldsamt LA, Clatts MC, Parker MM, et al.: Prevalence of sexually acquired antiretroviral drug resistance in a community sample of HIV-positive men who have sex with men in New York City. AIDS Patient Care STDS 2011;25:287-293.
14. Yerly S, Junier T, Gayet-Ageron A, et al.: The impact of transmission clusters on primary drug resistance in newly diagnosed HIV-1 infection. AIDS 2009;23:1415-1423.
15. Parker MM, Gordon D, Reilly A, et al.: Prevalence of drug-resistant and nonsubtype B HIV strains in antiretroviral-naive, HIV-infected individuals in New York State. AIDS Patient Care STDS 2007;21:644-652.
16. Cane PA, Green H, Fearnhill E, Dunn D, and the UK collaborative group on HIV Drug Resistance: Identification of accessory mutations associated with high-level resistance in HIV-1 reverse transcriptase. AIDS 2007;21:447-455.
17. Svicher V, Sing T, Santoro MM, et al.: Involvement of novel human immunodeficiency virus type 1 reverse transcriptase mutations in the regulation of resistance to nucleoside inhibitors. J Virol 2006;80:7186-7198.
18. Huigen MC, van Ham PM, de Graaf L, Kagan RM, Boucher CA, and Nijhuis M: Identification of a novel resistance (E40F) and compensatory (K43E) substitution in HIV-1 reverse transcriptase. Retrovirology 2008;5:20-31.
19. Garriga C, Pérez-Elías MJ, Delgado R, et al.: HIV-1 reverse transcriptase thumb subdomain polymorphisms associated with virological failure to nucleoside drug combinations. J Antimicrob Chemother 2009;64:251-258.
20. Betancor G, Puertas MC, Nevot M, et al.: Mechanisms involved in the selection of HIV-1 reverse transcriptase thumb subdomain polymorphisms associated with nucleoside analogue therapy failure. Antimicrob Agents Chemother 2010; 54:4799-4811.